Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma
Sarr, A.; Sow, A.M.; Diallo, A.; Mendez, V.; Ka Cisse, M.
Dakar Medical Spec No: 21-23
1996
ISSN/ISBN: 0049-1101 PMID: 14520981 Document Number: 459192
Document emailed within 1 workday
Related Documents
Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203Jiang, M.D. 1993: Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 73(3): 131-134; 189
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Koyama, H.; Nishizawa, Y.; Kinoshita, H.; Fujimoto, T.; Morii, H. 1988: Hepatocellular carcinoma with occult chronic hepatitis--hepatitis B virus as a pathogenetic factor of hepatocellular carcinoma Osaka City Medical Journal 34(1): 51-66
Shapiro, I.I.; Shabrov, A.V.; Karev, V.E.; Leenman, E.E.; Kvetnoĭ, I.M.; Tsinzerling, V.A.; Sologub, T.V. 2005: Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus Arkhiv Patologii 67(2): 6-10
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46
Tu, H.; Gao, H.-f.; Ma, G.-h.; Liu, Y. 2006: Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B Zhonghua Yi Xue Za Zhi 86(18): 1249-1252
Huang, M.J.; Liaw, Y.F. 1990: Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma American Journal of Gastroenterology 85(3): 281-284
Watanabe, H.; Ueno, Y. 2015: Seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in hepatitis B virus patients during nucleoside/nucleotide analog therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 459-465
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Brechot, C.; Wain-Hobson, S.; Pourcel, C.; Dejean, A.; Hadchouel, M.; Scotto, J.; Tiollais, P. 1983: Hepatitis B virus DNA and human hepatocellular carcinoma Progress in Clinical and Biological Research 132d: 495-504
Matsubara, K. 1989: Hepatitis B virus: DNA integration and hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 2): 530-541
Celen, M.K.; Ayaz, C.; Hosoglu, S.; Geyik, M.F.; Ulug, M. 2006: Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey Saudi Medical Journal 27(5): 617-620
Ishikawa, T.; Ichida, T. 2001: Features of hepatitis B virus-related hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 435-439
Akkiz, H.; Colakoğlu, S.; Köksal, F.; Korkut, H.; Hafta, A. 1996: Hepatitis C virus genotypes in patients with hepatocellular carcinoma Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 15(2-4): 85-88
Sánchez Casado, M.L.; Calderón Morales, M.T.; Muñoz Sanz, A.; Iradier Barrios, C. 1988: Seroprevalence of hepatitis B virus and human immunodeficiency virus infections in the personnel of a general hospital Medicina Clinica 91(16): 637
Parande, M.V.; Mantur, B.G.; Parande, A.M.; Shinde, R.S.; Roy, S.; Jnaneshwar, K.B.; Chandrashekhar, M.R. 2013: Seroprevalence of human immunodeficiency virus and hepatitis B virus co-infection in Belgaum, southern India Indian Journal of Medical Research 138(3): 364-365
Mwangi, J.; Gatei, D.G. 1993: Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya East African Medical Journal 70(4 Suppl): 34-36